Key result
Highly active Factor VIIa variants enhance catalytic efficiency via TF mimicry or active site optimization.
Why the study?
The conformational effects and mechanisms underlying enhanced intrinsic activity of Factor VIIa analogs with site-directed mutations were not fully understood.
The study reveals that enhanced catalytic efficiency in highly active Factor VIIa variants is achieved through distinct allosteric mechanisms.
No takes yet. Share an insight, caveat, or question.
May inform FVIIa variant engineering; extends mechanistic insights but leaves clinical translation open.
Rand et al. (2008) studied Blood coagulation. Site-directed mutagenesis of Factor VIIa vs. Wild-type Factor VIIa was evaluated on Conformational changes and hydrogen exchange protection. Hydrogen exchange mass spectrometry revealed that highly active Factor VIIa variants achieve enhanced catalytic efficiency through distinct mechanisms, either by partial mimicry of TF-induced activation or active site optimization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: